Treatment - Cancer Currents Blog

<!DOCTYPE html> <html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#"> <head> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta charset="utf-8" /> <script>window.CDEConfig = { "exitDisclaimerHref":{ "en":"\/policies\/linking", "es":"\/espanol\/politicas\/enlaces" }, "showFloatingDelighters":true, "environmentConfig":{ }, "glossaryConfig":{ "apiServer":"https:\/\/webapis.cancer.gov\/glossary\/v1\/" }, "drugDictionaryConfig":{ "apiServer":"https:\/\/webapis.cancer.gov\/drugdictionary\/v1\/" }, "ctsConfig":{ "apiServer":"https:\/\/clinicaltrialsapi.cancer.gov\/api\/v2", "printApiBase":"https:\/\/www.cancer.gov\/CTS.Print", "zipConversionEndpoint":"\/cts_api\/zip_code_lookup" }, "r4rConfig":{ "apiServer":"https:\/\/webapis.cancer.gov\/r4r\/v1" }, "general":{ "apiServer":"https:\/\/webapis.cancer.gov", "mediaServer":"https:\/\/nci-media.cancer.gov" }, "sitewideSearchConfig":{ "bestBetsApiServer":"https:\/\/webapis.cancer.gov\/bestbets\/v1\/", "searchApiServer":"https:\/\/webapis.cancer.gov\/sitewidesearch\/v1\/" }, "chartData": { "factBook": { "baseUrl": "\/about-nci\/budget\/fact-book", "dataType": "json" } } };</script> <script id="ncids-nav-info">window.ncidsNavInfo = { nav: { id: "860258", menu_type: "section-nav"}, item_id: 860258};</script> <meta name="description" content="The Cancer Currents blog provides news and research updates from the National Cancer Institute." /> <link rel="canonical" href="https://www.cancer.gov/news-events/cancer-currents-blog" /> <meta http-equiv="content-language" content="en" /> <meta name="robots" content="index" /> <meta property="og:type" content="Website" /> <meta property="og:url" content="https://www.cancer.gov/news-events/cancer-currents-blog" /> <meta property="og:title" content="Treatment - Cancer Currents Blog" /> <meta property="og:description" content="The Cancer Currents blog provides news and research updates from the National Cancer Institute." /> <meta property="og:image" content="https://www.cancer.gov/sites/g/files/xnrzdm211/files/styles/cgov_social_media/public/cgov_image/media_image/2019-10/lab-tech-looking-at-stats-on-laptop.jpg" /> <meta name="cgdp.domain" content="cgov" /> <meta name="cgdp.template" content="default" /> <meta name="dcterms.subject" content="News and Events" /> <meta name="dcterms.type" content="cgvBlogSeries" /> <meta name="dcterms.coverage" content="nciglobal,ncienterprise" /> <meta name="dcterms.isPartOf" content="CancerCurrents" /> <meta name="dcterms.isReferencedBy" content="event1" /> <meta name="twitter:card" content="summary" /> <link rel="icon" href="https://www.cancer.gov/profiles/custom/cgov_site/themes/custom/cgov/static/images/design-elements/icons/favicons/favicon.ico" sizes="32x32"/> <link rel="icon" href="https://www.cancer.gov/profiles/custom/cgov_site/themes/custom/cgov/static/images/design-elements/icons/favicons/favicon.svg" type="image/svg+xml"/> <link rel="apple-touch-icon" href="https://www.cancer.gov/profiles/custom/cgov_site/themes/custom/cgov/static/images/design-elements/icons/favicons/apple-touch-icon.png"/> <link rel="manifest" href="https://www.cancer.gov/profiles/custom/cgov_site/themes/custom/cgov/static/images/design-elements/icons/favicons/site.webmanifest"/> <meta name="x-no-op" content="none" /> <meta name="Generator" content="Drupal 10 (https://www.drupal.org)" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, user-scalable=yes, initial-scale=1, minimum-scale=1" /> <script id="cgov-adobe-url" type="text/javascript" src="//assets.adobedtm.com/6a4249cd0a2c/949e98979342/launch-5f2a5357bf66.min.js" async="async"></script> <script type="application/ld+json">{ "@context": "https://schema.org", "@graph": [ { "@type": "WebSite", "name": "National Cancer Institute (.gov)", "url": "https://www.cancer.gov" } ] }</script> <link rel="alternate" hreflang="en" href="https://www.cancer.gov/news-events/cancer-currents-blog" /> <link rel="alternate" hreflang="es" href="https://www.cancer.gov/espanol/noticias/temas-y-relatos-blog" /> <title>Treatment - Cancer Currents Blog - NCI</title> <link rel="preconnect" href="https://static.cancer.gov" /> <link rel="preconnect" href="https://fonts.googleapis.com"> <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin> <link href="https://fonts.googleapis.com/css2?family=Open+Sans:ital,wght@0,300;0,400;0,600;0,700;1,300;1,400;1,600;1,700&family=Poppins:ital,wght@0,300;0,400;0,500;0,600;1,300;1,400;1,500;1,600&family=Roboto+Mono:ital,wght@0,300;0,400;0,700;1,300;1,400;1,700&display=swap" rel="stylesheet"> <meta name="apple-mobile-web-app-title" content="Cancer.gov" /> <meta name="application-name" content="Cancer.gov" /> <link rel="stylesheet" media="all" href="/sites/g/files/xnrzdm211/files/css/css_0c3pwaxuQmeWVgPRWJtegrZ7sDiTQ8KSYZAxin88WNY.css?delta=0&language=en&theme=ncids_trans&include=eJwrriwuSc3VT0osTtUpy0wtL9YHk3q5-SmlOak6ecmZKcXxJUWJecX6STn56cUAzvIS5Q" /> <link rel="stylesheet" media="all" href="/profiles/custom/cgov_site/themes/custom/ncids_trans/dist/css/ncids-common.css?smm34w" /> <link rel="stylesheet" media="all" href="/profiles/custom/cgov_site/themes/custom/ncids_trans/dist/css/blogs.css?smm34w" /> </head> <body class="has-translated-content"> <a href="#main-content" class="usa-skipnav"> Skip to main content </a> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <section id="usa-banner" class="usa-banner" aria-label="Official government website"> <header class="usa-banner__header"> <div class="usa-banner__inner"> <div class="usa-banner__header-text"> An official website of the United States government </div> <a href="/espanol/noticias/temas-y-relatos-blog?topic=tratamiento" id="lang-toggle" class="usa-button usa-button--nci-small" hreflang="es">Español</a> </div> </header> </section> <header id="nci-header" class="nci-header nci-header--megamenu" data-base-path="/"> <div class="nci-header__navbar"> <div class="nci-logo" id="extended-mega-logo"> <a href="/" aria-label="National Cancer Institute Home Page"> <picture><source media="(min-width: 1024px)" srcset="/sites/g/files/xnrzdm211/files/ncids_header/logos/Logo_NCI.svg" /> <img src="/sites/g/files/xnrzdm211/files/ncids_header/logos/Logo_NCI_Mobile.svg" alt="" /> </picture> </a> </div> <div class="nci-header-nav__secondary"> <button class="usa-button nci-header-mobilenav__open-btn">Menu</button> <form class="nci-header-search" method="get" action="/search/results" role="search"> <label class="usa-sr-only" for="nci-header-search__field"> Search </label> <input class="usa-input" id="nci-header-search__field" type="search" name="swKeyword" data-autosuggest-collection="cgov"/> <button class="usa-button nci-header-search__search-button" type="submit" aria-label="Search"> <span class="nci-header-search__label" aria-hidden="true">Search</span> <svg class="usa-icon" xmlns="http://www.w3.org/2000/svg" role="img" viewbox="0 0 24 24" aria-hidden="true"> <path d="M0 0h24v24H0z" fill="none"/> <path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z"/> </svg> </button> </form> </div> </div> <nav aria-label="Primary navigation" class="nci-header-nav"> <div class="nci-header-nav__inner"> <ul class="nci-header-nav__primary"> <li class="nci-header-nav__primary-item"> <a href="/about-cancer" class="nci-header-nav__primary-link" data-menu-id="829"> <span>About Cancer</span> </a> </li> <li class="nci-header-nav__primary-item"> <a href="/types" class="nci-header-nav__primary-link" data-menu-id="11868"> <span>Cancer Types</span> </a> </li> <li class="nci-header-nav__primary-item"> <a href="/research" class="nci-header-nav__primary-link" data-menu-id="12732"> <span>Research</span> </a> </li> <li class="nci-header-nav__primary-item"> <a href="/grants-training" class="nci-header-nav__primary-link" data-menu-id="914792"> <span>Grants & Training</span> </a> </li> <li class="nci-header-nav__primary-item"> <a href="/news-events" class="nci-header-nav__primary-link usa-current" data-menu-id="12664"> <span>News & Events</span> </a> </li> <li class="nci-header-nav__primary-item"> <a href="/about-nci" class="nci-header-nav__primary-link" data-menu-id="10952"> <span>About NCI</span> </a> </li> </ul> </div> </nav> </header> <div class="grid-container"> <div class="grid-row flex-no-wrap"> <div class="grid-col-10"> <nav class="usa-breadcrumb usa-breadcrumb--wrap" aria-label="Breadcrumbs"> <ol class="usa-breadcrumb__list"> <li class="usa-breadcrumb__list-item"> <a href="/" class="usa-breadcrumb__link"> <span>Home</span> </a> </li> <li class="usa-breadcrumb__list-item"> <a href="/news-events" class="usa-breadcrumb__link"> <span>News & Events</span> </a> </li> <li class="usa-breadcrumb__list-item"> <a href="/news-events/cancer-currents-blog" class="usa-breadcrumb__link"> <span>Cancer Currents Blog</span> </a> </li> <li class="usa-breadcrumb__list-item usa-current" aria-current="page"> <span>Cancer Currents: An NCI Cancer Research Blog</span> </li> </ol> </nav> </div> <section class="cgdp-page-options cgdp-page-options--top" aria-label="Page options top"> <button class="usa-button usa-button--unstyled" onclick="window.print()"> <svg xmlns="http://www.w3.org/2000/svg" height="24" viewBox="0 0 24 24" width="24" class="usa-icon" role="img" aria-hidden="true" focusable="false"> <path d="M0 0h24v24H0z" fill="none"/> <path d="M19 8H5c-1.66 0-3 1.34-3 3v6h4v4h12v-4h4v-6c0-1.66-1.34-3-3-3zm-3 11H8v-5h8v5zm3-7c-.55 0-1-.45-1-1s.45-1 1-1 1 .45 1 1-.45 1-1 1zm-1-9H6v4h12V3z"/> </svg> <span class="usa-sr-only"> Print </span> </button> <a class="usa-button usa-button--unstyled" href="mailto:?subject=Information from the National Cancer Institute Web Site &body=I found this information on www.cancer.gov and I'd like to share it with you: https://www.cancer.gov/news-events/cancer-currents-blog %0D%0A%0D%0A NCI's Web site, www.cancer.gov, provides accurate, up-to-date, comprehensive cancer information from the U.S. government's principal agency for cancer research. If you have questions or need additional information, we invite you to contact NCI's LiveHelp instant messaging service at https://livehelp.cancer.gov, or call the NCI's Contact Center 1-800-4-CANCER (1-800-422-6237) (toll-free from the United States)."> <svg xmlns="http://www.w3.org/2000/svg" height="24" viewBox="0 0 24 24" width="24" class="usa-icon" role="img" aria-hidden="true" focusable="false"> <path d="M0 0h24v24H0z" fill="none"/> <path d="M20 4H4c-1.1 0-1.99.9-1.99 2L2 18c0 1.1.9 2 2 2h16c1.1 0 2-.9 2-2V6c0-1.1-.9-2-2-2zm0 14H4V8l8 5 8-5v10zm-8-7L4 6h16l-8 5z"/> </svg> <span class="usa-sr-only"> Email </span> </a> </section> </div> </div> <div id="page" class="grid-container"> <div class="grid-row grid-gap"> <div data-drupal-messages-fallback class="hidden"></div> <div class="cgdpl desktop:grid-col-9"> <main id="main-content" class="contentzone"> <div>  <article> <div class="resize-content"> <h1> <span> Treatment - Cancer Currents Blog </span> </h1> <div id="nvcgSubTitle"> <div class="subscribeRSS"> <a class="blogRSS" href="https://public.govdelivery.com/accounts/USNIHNCI/subscriber/new?topic_id=USNIHNCI_38"><span>Subscribe</span></a> </div> </div> <div id="cgvBody" class="cgvtopicpage"> <div class="slot-item first-SI"> <div class="blog-intro-text"> <p>Cancer treatment related news, with context from leading experts. Includes articles on new therapies, treatment side effects, and important trends in treatment-related research.</p> </div> </div> <div class="slot-item last-SI"> <div class="dynamic list has-images"> <ul> <div class="views-element-container"><div class="js-view-dom-id-5c3cff367268983f5f8fc2e40105eb9f693ffc3ecb0c8d77f230d636e6da7369"> <div class="item-list"> <ul> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/prostate-cancer-sbrt-effective-safe"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-11/Prostate-Radiation-Therapy.jpg?h=ed835807&itok=8d0_2NVI" width="228" height="171" alt="An imaging scan of the prostate and surrounding area depicting an SBRT treatment plan." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/prostate-cancer-sbrt-effective-safe" onclick=""> <span>Trial Results Support SBRT as a Standard Option for Some Prostate Cancers</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-11-21T12:00:00Z">November 21, 2024</time>, by Sharon Reynolds </div> <p>In a trial, men who received stereotactic body radiotherapy (SBRT) didn’t have a higher risk of cancer recurrence than men treated with other common radiation therapy regimens that are given over longer periods.</p> <p><a href="/news-events/cancer-currents-blog/2024/prostate-cancer-sbrt-effective-safe">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/hodgkin-lymphoma-nivolumab-avd-first-line"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-11/OCC-hodgkin-lymphoma-FDG-PET-110724.jpg?h=fe53820d&itok=muIe2kFT" width="228" height="171" alt="An FDG-PET scan of a man with Hodgkin lymphoma showing cancer (marked by areas of red and yellow-orange) throughout the upper body." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/hodgkin-lymphoma-nivolumab-avd-first-line" onclick=""> <span>Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin Lymphoma</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-11-14T12:00:00Z">November 14, 2024</time>, by Carmen Phillips </div> <p>In a nearly 1,000-patient trial, treatment with nivolumab (Opdivo) and the chemotherapy regimen AVD was better at eliminating cancer and keeping it at bay than the current standard initial treatment for the disease, AVD and brentuximab (Adcetris). The nivolumab combination also had fewer side effects.</p> <p><a href="/news-events/cancer-currents-blog/2024/hodgkin-lymphoma-nivolumab-avd-first-line">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/bladder-cancer-extended-versus-standard-lymph-node-surgery"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-11/OCC-lymph-node-surgery-bladder-110624.jpg?h=c02e2c54&itok=fkaGqRpg" width="228" height="171" alt="Illustration of the pelvic region showing the bladder with nearby lymph node-containing regions highlighted in different colors." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/bladder-cancer-extended-versus-standard-lymph-node-surgery" onclick=""> <span>Bladder Cancer Trial Finds Extended Lymph Node Surgery Doesn’t Improve Survival</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-11-06T12:00:00Z">November 6, 2024</time>, by Edward Winstead </div> <p>A randomized clinical trial comparing two types of surgery in people with localized muscle-invasive bladder cancer found that more extensive surgery removing a larger group of lymph nodes did not improve survival, compared with standard lymph node surgery.</p> <p><a href="/news-events/cancer-currents-blog/2024/bladder-cancer-extended-versus-standard-lymph-node-surgery">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/leiomyosarcoma-yondelis-doxorubicin-improve-survival"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-10/Woman%20receiving%20chemo-iStock.jpg?h=71822ace&itok=V6-OOQim" width="228" height="171" alt="A middle-aged woman in a reclining chair receiving chemotherapy" /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/leiomyosarcoma-yondelis-doxorubicin-improve-survival" onclick=""> <span>Combination Chemo Helps People with Leiomyosarcoma Live Longer</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-10-02T12:00:00Z">October 2, 2024</time>, by Sharon Reynolds </div> <p>Results from a French clinical trial have identified what experts say should now be the recommended initial treatment of advanced leiomyosarcoma. In the trial, the combination of trabectedin (Yondelis) and doxorubicin improved survival by a median of 9 months.</p> <p><a href="/news-events/cancer-currents-blog/2024/leiomyosarcoma-yondelis-doxorubicin-improve-survival">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/breast-cancer-jaw-osteonecrosis-antiresorptive"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-09/jaw%20osteonecrosis%20-%20open%20access%20Case%20Rep%20Oncol%20Med%202014.JPG?h=a7dc5b2b&itok=STV_02_p" width="228" height="171" alt="A CT scan of a jaw with an arrow pointing to an open area in the bone." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/breast-cancer-jaw-osteonecrosis-antiresorptive" onclick=""> <span>Jaw Problems Linked to Bone-Modifying Drugs Not as Rare as Once Thought</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-09-26T12:00:00Z">September 26, 2024</time>, by Nadia Jaber </div> <p>Osteonecrosis of the jaw was thought to be a rare side effect of drugs like denosumab (Xgeva) that lessen bone problems when cancer has spread to the bone. But a new study has found that the painful side effect is more common than once thought.</p> <p><a href="/news-events/cancer-currents-blog/2024/breast-cancer-jaw-osteonecrosis-antiresorptive">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/gist-uninterrupted-gleevec-treatment"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-09/GIST-illustration.jpg?h=9dd44f53&itok=K_fbLbIC" width="228" height="171" alt="An anatomic illustration showing the different organ sites where and how often GIST develops." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/gist-uninterrupted-gleevec-treatment" onclick=""> <span>Clinical Trial Results Support Uninterrupted Use of Imatinib for Some Gastrointestinal Stromal Tumors </span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-09-19T12:00:00Z">September 19, 2024</time>, by Edward Winstead </div> <p>Trial participants who stopped imatinib had a more rapid worsening of disease, a shorter time until resistance, and did not live as long as participants who continued the therapy uninterrupted.</p> <p><a href="/news-events/cancer-currents-blog/2024/gist-uninterrupted-gleevec-treatment">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/car-t-cell-therapy-second-cancers"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-08/T%20cell%20attacking%20cancer%20cell%20-%20iStock.jpg?h=163ac38c&itok=hiFexDM-" width="228" height="171" alt="A conceptual illustration of a T cell attacking a cancer cell" /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/car-t-cell-therapy-second-cancers" onclick=""> <span>Understanding the Risk of Second Cancers After CAR T-Cell Therapy</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-08-13T12:00:00Z">August 13, 2024</time>, by Carmen Phillips </div> <p>In late 2023, FDA announced it was investigating instances of second cancers following treatment with CAR T-cell therapies. In this Q&A, NCI’s Dr. Stephanie Goff explains what’s known about the issue, stressing that second cancers “of any kind are rare.”</p> <p><a href="/news-events/cancer-currents-blog/2024/car-t-cell-therapy-second-cancers">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/endometrial-cancer-durvalumab-pembrolizumab-chemotherapy"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-08/Immune%20cell%20killing%20cancer%20cell2_0.jpg?h=d017d680&itok=LPtBVKfX" width="228" height="171" alt="A stylized image of an immune cell attacking a cancer cell." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/endometrial-cancer-durvalumab-pembrolizumab-chemotherapy" onclick=""> <span>More Immunotherapy Options Approved for Treating Endometrial Cancer</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-08-06T12:00:00Z">August 6, 2024</time>, by Sharon Reynolds </div> <p>People with advanced endometrial cancer now have new FDA-approved treatment options: pembrolizumab and durvalumab, paired with chemotherapy, for tumors with a genetic change called mismatch repair deficiency. The agency also expanded the approved uses of dostarlimab for the disease. </p> <p><a href="/news-events/cancer-currents-blog/2024/endometrial-cancer-durvalumab-pembrolizumab-chemotherapy">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/lorlatinib-alk-positive-lung-cancer-initial-treatment"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-07/NSCLC-brain-mets-horizontal.png?h=c3216c32&itok=G_GfANiH" width="228" height="171" alt="Cross section image of a person's head showing four brain metastases circled in red." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/lorlatinib-alk-positive-lung-cancer-initial-treatment" onclick=""> <span>Lorlatinib Slows Growth of ALK-Positive Lung Cancers, May Prevent Brain Metastases</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-07-10T12:00:00Z">July 10, 2024</time>, by Edward Winstead </div> <p>Lorlatinib (Lorbrena) is superior to crizotinib (Xalkori) as an initial treatment for people with ALK-positive advanced non-small cell lung cancer, according to new clinical trial results. Treatment with lorlatinib also helped prevent new brain metastases.</p> <p><a href="/news-events/cancer-currents-blog/2024/lorlatinib-alk-positive-lung-cancer-initial-treatment">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/esophageal-cancer-flot-perioperative-chemotherapy"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-07/stage%202b%20esophageal%20cancer.jpg?h=67841823&itok=oi8GD6Kj" width="228" height="171" alt="anatomic illustration of stage 2b esophageal cancer, with pop out of cancer cells in nearby lymph nodes " /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/esophageal-cancer-flot-perioperative-chemotherapy" onclick=""> <span>Trial Establishes Preferred Treatment for Some People with Esophageal Cancer</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-07-09T12:00:00Z">July 9, 2024</time>, by Linda Wang </div> <p>For people with locally advanced esophageal cancer, a chemotherapy regimen called FLOT is the preferred treatment, according to results from a large clinical trial. People treated with FLOT lived much longer than those treated with the CROSS regimen.</p> <p><a href="/news-events/cancer-currents-blog/2024/esophageal-cancer-flot-perioperative-chemotherapy">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/small-cell-lung-cancer-imfinzi-increases-survival"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-06/Small%20Cell%20Lung%20Cancer%20Staging-high%20res.png?h=0a46cb20&itok=HdVKBpZ5" width="228" height="171" alt="Icons of organs showing that limited stage lung cancer is limited to one side of the lungs while extensive stage lung cancer is in both sides of the lungs and other organs like the brain, bone, and liver." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/small-cell-lung-cancer-imfinzi-increases-survival" onclick=""> <span>Durvalumab Extends Lives of People with Early-Stage Small Cell Lung Cancer</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-06-25T12:00:00Z">June 25, 2024</time>, by Nadia Jaber </div> <p>The immunotherapy drug durvalumab (Imfinzi) can help people with early-stage small cell lung cancer live longer, results from a large clinical trial show. Three years after starting treatment, nearly 60% of people who received the drug were still alive.</p> <p><a href="/news-events/cancer-currents-blog/2024/small-cell-lung-cancer-imfinzi-increases-survival">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/cancer-drugs-lower-doses"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-06/pill%20cutter.jpg?h=de88ceb6&itok=P2xJaP-v" width="228" height="171" alt="An image of white pills in a gray, plastic pill cutter" /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/cancer-drugs-lower-doses" onclick=""> <span>Spurred by Survivors, Researchers Are Revisiting Cancer Drug Doses</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-06-05T12:00:00Z">June 5, 2024</time>, by Linda Wang </div> <p>When it comes to cancer drugs, researchers are moving away from a paradigm called the maximum tolerated dose. Instead, they’re focusing more on identifying doses that produce fewer side effects but are still effective against a person’s cancer. </p> <p><a href="/news-events/cancer-currents-blog/2024/cancer-drugs-lower-doses">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/pediatric-low-grade-glioma-tovorafenib-braf"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-05/occ-cc-tumor-open-access-image-edit-052024.png?h=1e6eb8d0&itok=UHQxEA6i" width="228" height="171" alt="An MRI scan showing a side view of a child with a low-grade glioma in the lower back of the brain. " /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/pediatric-low-grade-glioma-tovorafenib-braf" onclick=""> <span>Tovorafenib Approved for Some Children with Low-Grade Glioma</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-05-28T12:00:00Z">May 28, 2024</time>, by Sharon Reynolds </div> <p>FDA has granted an accelerated approval to tovorafenib (Ojemda) for kids and teens who have low-grade glioma with changes in the BRAF gene. In a small clinical trial, the drug shrank or completely eliminated tumors in nearly 70% of patients.</p> <p><a href="/news-events/cancer-currents-blog/2024/pediatric-low-grade-glioma-tovorafenib-braf">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/kidney-cancer-pembrolizumab-increases-survival"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-05/kidney%20cancer%20stage%203%20v2.JPG?h=f79d4081&itok=Kuo5zsHW" width="228" height="171" alt="An anatomic illustration of stage 3 kidney cancer" /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/kidney-cancer-pembrolizumab-increases-survival" onclick=""> <span>Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-05-21T12:00:00Z">May 21, 2024</time>, by Carmen Phillips </div> <p>In a large clinical trial, treatment with pembrolizumab after surgery helped people with kidney cancer live longer than those who got a placebo and standard monitoring. The findings mark the first time an adjuvant treatment for kidney cancer has improved survival.</p> <p><a href="/news-events/cancer-currents-blog/2024/kidney-cancer-pembrolizumab-increases-survival">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/fda-alectinib-lung-cancer-alk-positive"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-05/stage%202b%20NSCLC-3.JPG?h=c167029a&itok=xpyEN5nb" width="228" height="171" alt="Illustration of a male figure showing the anatomy of the lungs with stage 2B lung cancer" /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/fda-alectinib-lung-cancer-alk-positive" onclick=""> <span>Alectinib Approved as an Adjuvant Treatment for Lung Cancer</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-05-08T12:00:00Z">May 8, 2024</time>, by Sharon Reynolds </div> <p>FDA has approved alectinib (Alecensa) as adjuvant therapy for people with lung cancer who have ALK-positive tumors. In a clinical trial, alectinib helped people live longer after surgery without their cancer returning than chemotherapy.</p> <p><a href="/news-events/cancer-currents-blog/2024/fda-alectinib-lung-cancer-alk-positive">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/fda-enhertu-her2-positive-solid-tumors"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-04/iStock%20female%20doctor%20with%20older%20black%20male%20patient.jpg?h=6f9d72ee&itok=1lYdEzmu" width="228" height="171" alt="A young female doctor shows information on a tablet computer to an older black male patient." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/fda-enhertu-her2-positive-solid-tumors" onclick=""> <span>FDA Approves Trastuzumab Deruxtecan for Any HER2-Positive Solid Cancer</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-05-03T12:00:00Z">May 3, 2024</time>, by Carmen Phillips </div> <p>Trastuzumab deruxtecan (Enhertu) can now be used to treat any advanced solid cancer that produces high levels of the protein HER2 (HER2-positive tumors). FDA’s accelerated approval was based on findings from three clinical trials.</p> <p><a href="/news-events/cancer-currents-blog/2024/fda-enhertu-her2-positive-solid-tumors">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/fda-elahere-platinum-resistant-ovarian-cancer"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-04/ADC-drug-CancerCurrents.PNG?h=ba3b6c8c&itok=GyxV3DND" width="228" height="171" alt="" /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/fda-elahere-platinum-resistant-ovarian-cancer" onclick=""> <span>Approval of Elahere Expands Treatment Options for Some Advanced Ovarian Cancers</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-04-24T12:00:00Z">April 24, 2024</time>, by Linda Wang </div> <p>FDA approved mirvetuximab soravtansine-gynx (Elahere) to treat people with advanced, platinum-resistant ovarian cancer whose tumors overproduce a protein called FR-α. The full approval was based on the results of a large, randomized trial called MIRASOL, which showed Elahere improved survival for these people.</p> <p><a href="/news-events/cancer-currents-blog/2024/fda-elahere-platinum-resistant-ovarian-cancer">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/rusfertide-polycythemia-vera-fewer-phlebotomies"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-03/polycythemia.jpg?h=1e6eb8d0&itok=cO58KiV8" width="228" height="171" alt="Illustration of three test tubes filled with blood separated into layers of plasma, buffy coat, and red blood cells. The three tubes show the components of normal blood, anemia, and polycythemia." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/rusfertide-polycythemia-vera-fewer-phlebotomies" onclick=""> <span>Rusfertide Nearly Eliminates Need for Phlebotomies to Treat Polycythemia Vera</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-03-28T12:00:00Z">March 28, 2024</time>, by Shana Spindler </div> <p>Adding rusfertide to treatment for polycythemia vera cut phlebotomy rates from nine to less than one per year in a recent clinical trial. The finding may improve the quality of life for those who manage the blood cancer with frequent blood draws. </p> <p><a href="/news-events/cancer-currents-blog/2024/rusfertide-polycythemia-vera-fewer-phlebotomies">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/cervical-cancer-simple-hysterectomy"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-03/Black%20woman%20in%20hospital%20with%20surgeon.jpg?h=2436f989&itok=trpl0mnC" width="228" height="171" alt="A middle-aged black woman in a hospital gown talking with a surgeon." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/cervical-cancer-simple-hysterectomy" onclick=""> <span>Simple Hysterectomy May Expand Treatment Options for Early-Stage Cervical Cancer</span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-03-27T12:00:00Z">March 27, 2024</time>, by Edward Winstead </div> <p>For some people with early-stage cervical cancer, a surgical procedure called a simple hysterectomy may be a safe and effective alternative to treatment with a radical hysterectomy, results from the SHAPE trial show. </p> <p><a href="/news-events/cancer-currents-blog/2024/cervical-cancer-simple-hysterectomy">Continue Reading ></a></p> </div> </div> </li> </li> <li> <li class="general-list-item general list-item"> <div class="list-item-image image container"> <a class="item-image image" href="/news-events/cancer-currents-blog/2024/kidney-cancer-subcutaneous-nivolumab"> <img loading="lazy" src="/sites/g/files/xnrzdm211/files/styles/cgov_thumbnail/public/cgov_image/media_image/2024-03/needle%20and%20vial.jpg?h=cf983afe&itok=EO8qcK9y" width="228" height="171" alt="A photograph of a syringe drawing medicine from a glass vial." /> </a> </div> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/kidney-cancer-subcutaneous-nivolumab" onclick=""> <span>Nivolumab Injections Could Make Treatment Easier for More People with Cancer </span> </a> <div class="description"> <div class="date-author"> <time datetime="2024-03-13T12:00:00Z">March 13, 2024</time>, by Nadia Jaber </div> <p>In a clinical trial, an injectable form of nivolumab (Opdivo) was as effective against kidney cancer as the intravenous form of the drug. Side effects were also similar and treatment time was shorter. Injectable immunotherapies, several experts said, if found to be comparable to IV forms, can be more convenient to receive and accessible to more people.</p> <p><a href="/news-events/cancer-currents-blog/2024/kidney-cancer-subcutaneous-nivolumab">Continue Reading ></a></p> </div> </div> </li> </li> </ul> </div> <div class="blog-pager clearfix"> <a class="older" href="/news-events/cancer-currents-blog?topic=treatment&page=1">< Older Posts</a> </div> </div> </div> </ul> </div> </div> </div> </div> <footer class="article-footer"> </footer> </article>  </div> </main> </div>   <div class="cgdpl desktop:grid-col-3"> <div id="nvcgSlListBlogRTRail" class="right-rail"> <div class="slot-item"> <div class="managed list with-date"> <h2 id="Featured+Posts">Featured Posts</h2> <ul> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/medical-cannabis-oncologists-patients-communication">Oncologists Struggle to Answer Questions About Medical Cannabis</a> <div class="byline"> <p> October 16, 2024, by Carmen Phillips </p> </div> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/mammogram-false-positives-affect-future-screening">Mammogram False Positives Can Affect Future Screening Behavior</a> <div class="byline"> <p> October 4, 2024, by Edward Winstead </p> </div> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog/2024/ancient-retrovirus-dna-ltr10-cancer">DNA From an Ancient Virus Helps Many Cancers Grow</a> <div class="byline"> <p> September 6, 2024, by Nadia Jaber </p> </div> </div> </li> </ul> </div> </div> <div class="slot-item"> <div class="managed list without-date"> <h2 id="Categories">Categories</h2> <ul> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=biology">Biology of Cancer</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=cancer-risk">Cancer Risk</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=childhood-cancer">Childhood Cancer</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=clinical-trial-results">Clinical Trial Results</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=disparities">Disparities</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=fda-approvals">FDA Approvals</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=global-health">Global Health</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=leadership-expert-views">Leadership & Expert Views</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=prevention">Prevention</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=prognosis">Prognosis</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=screening-early-detection">Screening & Early Detection</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=survivorship-supportive-care">Survivorship & Supportive Care</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=technology">Technology</a> </div> </li> <li class="general-list-item general list-item"> <div class="title-and-desc title desc container"> <a class="title" href="/news-events/cancer-currents-blog?topic=treatment">Treatment</a> </div> </li> </ul> </div> </div> <div class="slot-item"> <div class="desktop"> <div id="blog-archive-accordion"> <h2 id="archive" class="blog-archive-header"> Archive </h2> <div id="blog-archive-accordion-year"> <h3> 2024 </h3> <ul class="ui-helper-reset"> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2024&month=11"> November </a> (5) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2024&month=10"> October </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2024&month=09"> September </a> (5) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2024&month=08"> August </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2024&month=07"> July </a> (6) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2024&month=06"> June </a> (5) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2024&month=05"> May </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2024&month=04"> April </a> (6) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2024&month=03"> March </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2024&month=02"> February </a> (6) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2024&month=01"> January </a> (6) </li> </ul> <h3> 2023 </h3> <ul class="ui-helper-reset"> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=12"> December </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=11"> November </a> (6) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=10"> October </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=09"> September </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=08"> August </a> (6) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=07"> July </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=06"> June </a> (8) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=05"> May </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=04"> April </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=03"> March </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=02"> February </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2023&month=01"> January </a> (6) </li> </ul> <h3> 2022 </h3> <ul class="ui-helper-reset"> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=12"> December </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=11"> November </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=10"> October </a> (5) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=09"> September </a> (6) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=08"> August </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=07"> July </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=06"> June </a> (8) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=05"> May </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=04"> April </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=03"> March </a> (8) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=02"> February </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2022&month=01"> January </a> (6) </li> </ul> <h3> 2021 </h3> <ul class="ui-helper-reset"> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=12"> December </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=11"> November </a> (4) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=10"> October </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=09"> September </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=08"> August </a> (6) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=07"> July </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=06"> June </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=05"> May </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=04"> April </a> (8) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=03"> March </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=02"> February </a> (5) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2021&month=01"> January </a> (6) </li> </ul> <h3> 2020 </h3> <ul class="ui-helper-reset"> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=12"> December </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=11"> November </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=10"> October </a> (8) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=09"> September </a> (6) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=08"> August </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=07"> July </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=06"> June </a> (8) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=05"> May </a> (8) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=04"> April </a> (10) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=03"> March </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=02"> February </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2020&month=01"> January </a> (7) </li> </ul> <h3> 2019 </h3> <ul class="ui-helper-reset"> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=12"> December </a> (6) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=11"> November </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=10"> October </a> (8) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=09"> September </a> (8) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=08"> August </a> (6) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=07"> July </a> (8) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=06"> June </a> (6) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=05"> May </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=04"> April </a> (7) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=03"> March </a> (10) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=02"> February </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2019&month=01"> January </a> (6) </li> </ul> <h3> 2018 </h3> <ul class="ui-helper-reset"> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=12"> December </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=11"> November </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=10"> October </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=09"> September </a> (11) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=08"> August </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=07"> July </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=06"> June </a> (12) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=05"> May </a> (9) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=04"> April </a> (10) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=03"> March </a> (11) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=02"> February </a> (11) </li> <li class="month"> <a href="/news-events/cancer-currents-blog?year=2018&month=01"> January </a> (10) </li> </ul> </div> </div> </div> </div> </div> </div>  </div> <section class="cgdp-page-options cgdp-page-options--bottom" aria-label="Page options bottom"> <button class="usa-button usa-button--unstyled" onclick="window.print()"> <svg xmlns="http://www.w3.org/2000/svg" height="24" viewBox="0 0 24 24" width="24" class="usa-icon" role="img" aria-hidden="true" focusable="false"> <path d="M0 0h24v24H0z" fill="none"/> <path d="M19 8H5c-1.66 0-3 1.34-3 3v6h4v4h12v-4h4v-6c0-1.66-1.34-3-3-3zm-3 11H8v-5h8v5zm3-7c-.55 0-1-.45-1-1s.45-1 1-1 1 .45 1 1-.45 1-1 1zm-1-9H6v4h12V3z"/> </svg> <span class="usa-sr-only"> Print </span> </button> <a class="usa-button usa-button--unstyled" href="mailto:?subject=Information from the National Cancer Institute Web Site &body=I found this information on www.cancer.gov and I'd like to share it with you: https://www.cancer.gov/news-events/cancer-currents-blog %0D%0A%0D%0A NCI's Web site, www.cancer.gov, provides accurate, up-to-date, comprehensive cancer information from the U.S. government's principal agency for cancer research. If you have questions or need additional information, we invite you to contact NCI's LiveHelp instant messaging service at https://livehelp.cancer.gov, or call the NCI's Contact Center 1-800-4-CANCER (1-800-422-6237) (toll-free from the United States)."> <svg xmlns="http://www.w3.org/2000/svg" height="24" viewBox="0 0 24 24" width="24" class="usa-icon" role="img" aria-hidden="true" focusable="false"> <path d="M0 0h24v24H0z" fill="none"/> <path d="M20 4H4c-1.1 0-1.99.9-1.99 2L2 18c0 1.1.9 2 2 2h16c1.1 0 2-.9 2-2V6c0-1.1-.9-2-2-2zm0 14H4V8l8 5 8-5v10zm-8-7L4 6h16l-8 5z"/> </svg> <span class="usa-sr-only"> Email </span> </a> </section> </div> <div id="block-ncidsfooterenglish"> <footer class="usa-footer usa-footer--nci-big" id="nci-footer" aria-label="Footer" > <div class="grid-container usa-footer__return-to-top"> <a href="#top" aria-label="Back To Top"><span>Back To Top</span></a> </div> <div class="usa-footer__primary-section"> <div class="grid-container"> <div class="grid-row grid-gap"> <div class="tablet:grid-col-8"> <nav class="usa-footer__nav" aria-label="Footer navigation"> <div class="grid-row grid-gap-4"> <div class="mobile-lg:grid-col-6 desktop:grid-col-4"> <section class="usa-footer__primary-content usa-footer__primary-content--collapsible" > <div class="usa-footer__primary-link">About</div> <ul class="usa-list usa-list--unstyled"> <li class="usa-footer__secondary-link"> <a href="/about-website">About This Website</a> </li> <li class="usa-footer__secondary-link"> <a href="/espanol">en Español</a> </li> <li class="usa-footer__secondary-link"> <a href="/policies/copyright-reuse">Reuse & Copyright</a> </li> <li class="usa-footer__secondary-link"> <a href="/social-media">Social Media</a> </li> </ul> </section> </div> <div class="mobile-lg:grid-col-6 desktop:grid-col-4"> <section class="usa-footer__primary-content usa-footer__primary-content--collapsible" > <div class="usa-footer__primary-link">Resources</div> <ul class="usa-list usa-list--unstyled"> <li class="usa-footer__secondary-link"> <a href="/contact">Contact Us</a> </li> <li class="usa-footer__secondary-link"> <a href="/publications">Publications</a> </li> <li class="usa-footer__secondary-link"> <a href="/publications/dictionaries/cancer-terms" >Dictionary of Cancer Terms</a > </li> <li class="usa-footer__secondary-link"> <a href="/research/participate/clinical-trials-search" >Find a Clinical Trial</a > </li> </ul> </section> </div> <div class="mobile-lg:grid-col-6 desktop:grid-col-4"> <section class="usa-footer__primary-content usa-footer__primary-content--collapsible" > <div class="usa-footer__primary-link">Policies</div> <ul class="usa-list usa-list--unstyled"> <li class="usa-footer__secondary-link"> <a href="/policies/accessibility">Accessibility</a> </li> <li class="usa-footer__secondary-link"> <a href="/policies/foia">FOIA</a> </li> <li class="usa-footer__secondary-link"> <a href="/policies/privacy-security" >Privacy & Security</a > </li> <li class="usa-footer__secondary-link"> <a href="/policies/disclaimer">Disclaimers</a> </li> <li class="usa-footer__secondary-link"> <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" >Vulnerability Disclosure</a > </li> </ul> </section> </div> </div> </nav> </div> <div class="tablet:grid-col-4"> <div class="usa-sign-up"> <div class="usa-sign-up__heading">Sign up for email updates</div> <form action="https://public.govdelivery.com/accounts/USNIHNCI/subscribers/qualify" aria-label="Footer subscribe" class="usa-form" accept-charset="UTF-8" method="post" novalidate target="_blank" id="signup" > <input type="hidden" name="category_id" id="category_id" value="" /> <div class="usa-form-group"> <label class="usa-label" for="email"> Enter your email address </label> <input class="usa-input width-full" id="email" name="email" type="email" value="" /> </div> <button class="usa-button usa-button--accent-warm" type="submit"> Sign up </button> </form> </div> </div> </div> </div> </div> <div class="usa-footer__secondary-section"> <div class="grid-container"> <div class="grid-row grid-gap"> <div class="usa-footer__logo grid-row desktop:grid-col-5"> <div class="mobile-lg:grid-col-auto desktop:margin-bottom-3"> <p class="usa-footer__logo-heading"> <span class="logo__agency-name">National Cancer Institute </span> <span class="logo__parent-organization" >at the National Institutes of Health</span > </p> </div> </div> <div class="usa-footer__contact-links mobile-lg:grid-col-7"> <div class="usa-footer__contact-heading">Contact Us</div> <div class="usa-footer__address"> <div class="usa-footer__contact-info grid-row grid-gap"> <div class="tablet:grid-col-auto"> <a href="https://livehelp.cancer.gov/">Live Chat</a> </div> <div class="tablet:grid-col-auto"> <a href="tel:1-800-4-CANCER">1-800-4-CANCER</a> </div> <div class="tablet:grid-col-auto"> <a href="mailto:NCIinfo@nih.gov">NCIinfo@nih.gov</a> </div> <div class="tablet:grid-col-auto"> <a class="no-exit-notification" href="https://nci.az1.qualtrics.com/jfe/form/SV_aeLLobt6ZeGVn5I" target="_blank" >Site Feedback</a > </div> </div> </div> </div> </div> <div class="grid-row grid-gap"> <div class="usa-footer__social-links desktop:grid-col-5"> <div class="usa-footer__social-heading">Follow us</div> <div class="grid-row grid-gap-1 nci-big__social"> <div class="grid-col-auto"> <a class="usa-social-link no-exit-notification" href="https://www.facebook.com/cancer.gov" > <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="24" class="usa-icon" role="img" aria-labelledby="facebook-title" > <title id="facebook-title">Facebook</title> <rect fill="none" height="24" width="24" /> <path d="M22,12c0-5.52-4.48-10-10-10S2,6.48,2,12c0,4.84,3.44,8.87,8,9.8V15H8v-3h2V9.5C10,7.57,11.57,6,13.5,6H16v3h-2 c-0.55,0-1,0.45-1,1v2h3v3h-3v6.95C18.05,21.45,22,17.19,22,12z" /> </svg> </a> </div> <div class="grid-col-auto"> <a class="usa-social-link no-exit-notification" href="https://twitter.com/thenci" > <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" class="usa-icon" role="img" aria-labelledby="x-title" > <title id="x-title">Follow on X</title> <path d="M12 22c5.5 0 10-4.5 10-10S17.5 2 12 2 2 6.5 2 12s4.5 10 10 10zm5.2-15.6L13.3 11l4.3 6.2h-3.1L11.6 13 8 17.2h-.9l4.1-4.8-4.1-6h3.1l2.7 3.9 3.4-3.9h.9zm-5.6 5.4.4.6 2.8 4h1.4l-3.5-5-.4-.6-2.6-3.7H8.3l3.3 4.7z" /> </svg> </a> </div> <div class="grid-col-auto"> <a class="usa-social-link no-exit-notification" href="https://www.instagram.com/nationalcancerinstitute/" > <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" class="usa-icon" role="img" aria-labelledby="instagram-title" > <title id="instagram-title">Instagram</title> <g id="Instagram"> <path d="M12,10a2,2,0,1,0,2,2A2,2,0,0,0,12,10Z" /> <path d="M12,2A10,10,0,1,0,22,12,10,10,0,0,0,12,2Zm6,12.69A3.32,3.32,0,0,1,14.69,18H9.31A3.32,3.32,0,0,1,6,14.69V9.31A3.32,3.32,0,0,1,9.31,6h5.38A3.32,3.32,0,0,1,18,9.31Z" /> <path d="M16.94,9.31a2.25,2.25,0,0,0-2.25-2.25H9.31A2.25,2.25,0,0,0,7.06,9.31v5.38a2.25,2.25,0,0,0,2.25,2.25h5.38a2.25,2.25,0,0,0,2.25-2.25h0ZM12,15.09A3.09,3.09,0,1,1,15.09,12,3.09,3.09,0,0,1,12,15.09Zm3.77-5.75a.79.79,0,0,1-.55.23.83.83,0,0,1-.55-.23.78.78,0,0,1,0-1.11A.82.82,0,0,1,15.22,8a.78.78,0,0,1,.55,1.33Z" /> </g> </svg> </a> </div> <div class="grid-col-auto"> <a class="usa-social-link no-exit-notification" href="https://www.youtube.com/NCIgov" > <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" class="usa-icon" role="img" aria-labelledby="youtube-title" > <title id="youtube-title">Youtube</title> <g id="YouTube"> <path d="M12,2A10,10,0,1,0,22,12,10,10,0,0,0,12,2Zm5.75,12.91A1.49,1.49,0,0,1,16.69,16a34.65,34.65,0,0,1-4.69.26A34.65,34.65,0,0,1,7.31,16a1.49,1.49,0,0,1-1.06-1.06A15.88,15.88,0,0,1,6,12a15.88,15.88,0,0,1,.25-2.91A1.49,1.49,0,0,1,7.31,8,34.65,34.65,0,0,1,12,7.77,34.65,34.65,0,0,1,16.69,8a1.49,1.49,0,0,1,1.06,1.06A15.88,15.88,0,0,1,18,12,15.88,15.88,0,0,1,17.75,14.91Z" /> <polygon points="10.77 13.78 13.91 12 10.77 10.22 10.77 13.78" /> </g> </svg> </a> </div> <div class="grid-col-auto"> <a class="usa-social-link no-exit-notification" href="https://www.linkedin.com/company/nationalcancerinstitute/" > <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" class="usa-icon" role="img" aria-labelledby="linkedin-title" > <title id="linkedin-title">Linkedin</title> <g id="final"> <path d="M12,2C6.48,2,2,6.48,2,12s4.48,10,10,10s10-4.48,10-10S17.52,2,12,2z M8.912001,17.584H6.584v-7.472h2.328001V17.584z M7.744,9.104C6.992,9.104,6.4,8.488,6.4,7.76c0-0.752,0.592-1.344,1.344-1.344c0.728,0,1.343999,0.592,1.343999,1.344 C9.087999,8.488,8.472,9.104,7.744,9.104z M17.6,17.584h-2.328v-3.64c0-0.856-0.024001-1.967999-1.216001-1.967999 s-1.392,0.927999-1.392,1.912v3.696H10.36v-7.472h2.224v1.008h0.024c0.464-0.752,1.296-1.216001,2.199999-1.192 c2.352001,0,2.792,1.552001,2.792,3.544001C17.6,13.472,17.6,17.584,17.6,17.584z" /> </g> </svg> </a> </div> </div> </div> <div class="usa-footer__contact-links desktop:grid-col-7"> <div class="usa-footer__address height-full"> <div class="usa-footer__contact-info grid-row grid-gap height-full"> <address> <a href="https://www.hhs.gov/" >U.S. Department of Health and Human Services </a> <a href="https://www.nih.gov/" >National Institutes of Health </a> <a href="https://www.cancer.gov/">National Cancer Institute </a> <a href="https://usa.gov/">USA.gov</a> </address> </div> </div> </div> </div> </div> </div> </footer> </div> </div> <script src="/sites/g/files/xnrzdm211/files/js/js_qW3TLjdEty3QtOepUCSY4uh6BQEGkRIL3qUMnp3WXG4.js?scope=footer&delta=0&language=en&theme=ncids_trans&include=eJwrriwuSc3VT0osTtUpy0wtL9YHk3q5-SmlOak6ecmZKcXxJUWJecX6STn56cUAzvIS5Q"></script> <script src="/profiles/custom/cgov_site/themes/custom/ncids_trans/dist/js/ncids-common.js?smm34w"></script> <script src="/profiles/custom/cgov_site/themes/custom/ncids_trans/dist/js/blogs.js?smm34w"></script> </body> </html>

CINXE.COM

Treatment - Cancer Currents Blog - NCI